Blog Band - Page 211 of 254

Apr 2022

PharmaShots Interview: Fountain Therapeutics’ William Greene Shares Insights on the $15M Series A-2 Financing

In an interview with PharmaShots, William Greene, CEO at Fountain Therapeutics shares his views on the closing of $15M Series A-2 financing & how it supports the drug discovery platform and pipelineShots:The company closes $15M…

Apr 2022

VIEWPOINTS

PharmaShots Interview: Medidata’s Kelly McKee Shares Insight on Decentralized Clinical Trial

In an interview with PharmaShots, Kelly McKee, Vice President, Patient Registries & Recruitment at Medidata shared her views on the decentralized clinical trial networks through the collaboration with Circuit ClinicalShots:Medidata is investing…

Apr 2022

VIEWPOINTS

PharmaShots Interview: Abbott’s Allen Burton Shares Insight on Proclaim XR Spinal Cord Stimulation System for the Treatment of Chronic Intractable Pain of Trunk and Limbs

In an interview with PharmaShots, Dr. Allen Burton, Medical Director of Abbott’s Neuromodulation Business shared his views on the US FDA approval for expanded MRI compatibility of Its Proclaim XR SCS DeviceShots:The US FDA…

Apr 2022

INSIGHTS+

Insights+ Key Biosimilars Events of March 2022

Biosimilars are developed to be highly similar versions of approved biologics in terms of safety, purity, and potencyBiosimilars are expected to be a cost-effective alternative to the high-priced branded…

Apr 2022

VIEWPOINTS

PharmaShots Interview: SOTIO’ Richard Sachse Shares Insight on SOT101 for the Treatment of Advanced/Metastatic Solid Tumors

In an interview with PharmaShots, Richard Sachse, Chief Medical Officer & Managing Director at SOTIO shared his views on the data of SOT101 in the P-I/Ib (AURELIO-03) study for the treatment of advanced/metastatic solid tumorsShots:…

Apr 2022

VIEWPOINTS

PharmaShots Interview: Ikena Oncology’ Mark Manfredi Shares Insight on IK-930 for the Treatment of Solid Tumors

In an interview with PharmaShots, Mark Manfredi, President, and CEO at Ikena Oncology shared his views on the US FDA’s IND clearance of IK-930 for the treatment of solid tumors that harbors genetic alterations in the hippo…

Apr 2022

VIEWPOINTS

PharmaShots Interview: Frank Leebeek & Greta Mulder of Erasmus MC, Lutz Bonacker of CSL Behring Share Insight on Etranacogene Dezaparvovec for the Treatment of Hemophilia B

In an interview with PharmaShots, Frank Leebeek, MD, Ph.D., Hematology Department Head & Greta Mulders, Nurse Practitioner, Study Coordinator at the Erasmus Medical Center in Rotterdam, Lutz Bonacker, Senior Vice…

Mar 2022

INSIGHTS+

PharmaShots’ Key Highlights of First Quarter 2022

The first quarter of 2022 highlights the approvals, clinical data & acquisitions. There are major alliances in this quarter which include Biocon acquired Viatris’ biosimilars assets for ~$3.335B, Stryker signed…

Mar 2022

VIEWPOINTS

PharmaShots Interview: Seattle Children’s Research Institute’ Fred David Mast Shares Insight on Nanobodies for the Prevention of COVID-19

In an interview with PharmaShots, Fred David Mast, Senior Research Scientist at Seattle Children’s Research Institute shared his views on the study demonstrating that Nanobodies could be an exceptional resource for superior COVID-19 protective and…

Mar 2022

EXCLUSIVE

Exclusive Interview with PharmaShots: Jeremiah Robison of Cionic Shares Insight on Neural Sleeve for Neurological Disorders

In an interview with PharmaShots, Jeremiah Robison, Founder, and CEO at Cionic shared his views on the US FDA’s clearance of Neural Sleeve for patients with cerebral palsy, MS, stroke, and other disordersCionic’s Neural Sleeve…

PharmaShots Interview: Fountain Therapeutics’ William Greene Shares Insights on the $15M Series A-2 Financing

PharmaShots Interview: Medidata’s Kelly McKee Shares Insight on Decentralized Clinical Trial

PharmaShots Interview: Abbott’s Allen Burton Shares Insight on Proclaim XR Spinal Cord Stimulation System for the Treatment of Chronic Intractable Pain of Trunk and Limbs

Insights+ Key Biosimilars Events of March 2022

PharmaShots Interview: SOTIO’ Richard Sachse Shares Insight on SOT101 for the Treatment of Advanced/Metastatic Solid Tumors

PharmaShots Interview: Ikena Oncology’ Mark Manfredi Shares Insight on IK-930 for the Treatment of Solid Tumors

PharmaShots Interview: Frank Leebeek & Greta Mulder of Erasmus MC, Lutz Bonacker of CSL Behring Share Insight on Etranacogene Dezaparvovec for the Treatment of Hemophilia B

PharmaShots’ Key Highlights of First Quarter 2022

PharmaShots Interview: Seattle Children’s Research Institute’ Fred David Mast Shares Insight on Nanobodies for the Prevention of COVID-19

Exclusive Interview with PharmaShots: Jeremiah Robison of Cionic Shares Insight on Neural Sleeve for Neurological Disorders

Contact US

OUR INFORMATION

FOLLOW US